A detailed history of Capula Management LTD transactions in Amgen Inc stock. As of the latest transaction made, Capula Management LTD holds 500 shares of AMGN stock, worth $131,690. This represents 0.0% of its overall portfolio holdings.

Number of Shares
500
Previous 101 395.05%
Holding current value
$131,690
Previous $31,000 419.35%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$309.38 - $337.38 $205,428 - $224,020
664 Added 657.43%
765 $246,000
Q2 2024

Aug 05, 2024

BUY
$262.75 - $319.31 $26,537 - $32,250
101 New
101 $31,000
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $55,486 - $62,595
217 New
217 $62,000
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $218,341 - $258,184
-1,019 Reduced 52.53%
921 $204,000
Q1 2023

May 10, 2023

SELL
$225.79 - $275.2 $13.8 Million - $16.8 Million
-61,153 Reduced 96.93%
1,940 $468,000
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $3.56 Million - $4.52 Million
15,522 Added 32.63%
63,093 $16.6 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $10.7 Million - $12 Million
47,571 New
47,571 $10.7 Million
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $1.45 Million - $1.66 Million
-7,293 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $1.52 Million - $1.78 Million
7,164 Added 5553.49%
7,293 $1.55 Million
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $359,946 - $399,334
-1,541 Reduced 92.28%
129 $31,000
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $370,589 - $431,862
1,670 New
1,670 $416,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Capula Management LTD Portfolio

Follow Capula Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capula Management LTD with notifications on news.